Essential hypertension (EH) is considered to be multifactorial, and several factors have been identified. Several causal genes appear to contribute between 30 and 50% of the variation in blood pressure among individuals.
1 These genetic determinants interact with environmental factors such as dietary salt to produce the final disease phenotype. Despite significant recent progress in genomic and statistical tools, the genetic dissection of human EH remains a major challenge. 2 ATP-sensitive potassium (KATP) channels couple the intracellular energy state to membrane excitability, and regulate a wide array of biologic activities. 3 KATP channels contain a pore-forming inwardly rectifying potassium channel and a sulfonylurea receptor regulatory subunit (Sur1 or Sur2). 3 Surs are members of the ATP-binding cassette (ABC) transporter family of transmembrane proteins. The most extensive studies of the physiology and pharmacology of KATP channels have involved pancreatic b cells. Sulfonylurea agents such as glibenclamide inhibit KATP channels in pancreatic b cells by binding to Sur1, which results in closure of the channel and stimulation of insulin release. 4 Recent studies indicate that KATP channels and Surs are involved in the physiology of the cardiovascular system. 3 In cardiomyocytes, where KATP channels modulate protection from ischaemia, Sur1 and Sur2 are coexpressed. 3 In smooth muscle and voluntary striated muscle, only Sur2 is expressed. 3 In a 2003 study, mice with a targeted disruption of the Sur2 gene (Sur2À/À) had elevated resting blood pressure and experienced sudden death from coronary artery vasospasm with ST segment elevation. 5 Recently, genome-wide linkage analysis revealed that chromosome 12p, including Sur2 gene (located at chromosome 12p12.1), was a candidate locus for EH in Chinese families. Genetic linkage analysis was performed using 387 family members from seven generations of 32 Chinese nuclear families with EH. The 8-cM locus at 12p1-12p2 was found to have a parametric LOD score of 3.44. 4 These studies suggest that the Sur2 gene is closely related to the development of hypertension. However, there have been no reports of an association between the Sur2 gene and EH.
The aim of the present study was to investigate the association between EH and single-nucleotide polymorphisms (SNPs) in the human Sur2 gene in a Japanese population, using haplotype-based case-control analysis.
We selected 208 EH subjects and 200 normotensive (NT) subjects, using criteria described elsewhere. 6 Informed consent was obtained from each individual according to a protocol approved by the Human Studies Committee of Nihon University. 6 We selected seven SNPs in introns of the human Sur2 gene as markers for the genetic association experiment. The minor allele frequency of each SNP among Japanese was 420% (estimated in screening by the Celera Company), indicating that they are all effective genetic markers. All SNPs were confirmed using dbSNP at the website of the National Center for Biotechnology Information (NCBI) and the Applied Biosystems-Celera Discovery System, with the following accession numbers: rs12366938 (C_2881802_10), rs704217 (C_8875711_1_), rs4148666 (C_2881771_10), rs3782668 (C_2881761_10), rs704187 (C_2881756_10), rs2307024 (C_2881834_1_), rs704178 (C_2881823_10). For the present study, these SNPs were assigned temporary names from SNP1 to SNP7. Genotypes were determined using Assays-on-Demand kits (Applied Biosystems, Branchburg, NJ) and TaqMan s PCR, as described elsewhere. 7 We performed a haplotype-based case-control analysis of 127 combinations of the seven SNPs. The frequency of each haplotype was estimated using the expectation/maximization (EM) algorithm. 8 We used SNPAlyze version 3.2 for the haplotypebased case-control analysis and linkage disequilibrium (LD) analysis (DYNACOM Co. Ltd, Yokohama, Japan).
Hardy-Weinberg equilibrium was assessed by w 2 analysis. The statistical analyses of clinical data, overall distribution of alleles and data from haplotype-based case-control analysis were performed as described elsewhere. 7 There was no significant difference in overall distribution of any of the SNPs between the EH and NT groups.
In the haplotype-based case-control analysis (Table 1) , there were significant differences in prevalence of 10 of the 127 combinations of SNPs between the EH and NT groups. Distribution of individual haplotypes (major top five) and their P values are shown in Table 1 . There was a significant difference in prevalence of the A-C-T haplotype (designated haplotype H1) between the EH and NT groups (P ¼ 0.0046). 
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Patterns of LD of the Sur2 gene were calculated by their |D 0 | and r 2 values. All |D 0 | values were greater than 0.5, indicating that all SNPs were located in one haplotype block. Furthermore, the r 2 values were less than 0.1 for all combinations other than SNP1-SNP2, indicating that it is advantageous to isolate susceptibility haplotypes using all SNPs other than SNP2. In the haplotype-based case-control analysis, there was no significant difference in prevalence of combinations including SNP2 between the EH and NT groups.
False negative results are a common problem with haplotype-based case-control analysis as well as with case-control using individual SNPs. However, for genes with multiple susceptibility alleles, haplotype-based case-control analysis can have advantages over analysis based on individual SNPs, particularly when linkage disequilibrium between SNPs is weak. 9 The present findings should encourage further development of statistical methods based on haplotypes, to assess the potential of association methods for identification and location of complex disease genes. Positions of some susceptibility genes of multifactorial diseases have been identified using haplotype analysis. 10, 11 Based on such findings, we hypothesized that haplotypebased case-control analysis would be useful for assessing association between haplotypes and EH, resulting in the present attempt to establish haplotypes of the Sur2 gene consisting of SNPs. The present association analysis showed no association of individual SNPs with EH, indicating that these SNPs cannot be used as genetic markers of this condition. However, one haplotype (H1) had significantly lower frequency in the EH group after the Bonferroni correction.
The logistic regression analysis adjusted for age and sex indicated that smoking was an independent risk factor for CI (odds ratio ¼ 1.87, P ¼ 0.008, 95% CI: 1.18-2.97). We were unable to accurately estimate haplotypes for each subject using the computer software. Consequently, we could not analyze interaction between the effects of smoking and haplotypes.
Gong et al. 4 identified the region of chromosome 12p including the Sur2 gene as a candidate locus for EH in Chinese populations, by performing genetic linkage analysis using 387 family members from seven generations of 32 Chinese nuclear families with EH. Furthermore, very recently, Bahring et al. 12 studied a Turkish family in which members with autosomal-dominant hypertension and brachydactyly died of stroke before the age of 50 years. They found a chromosome 12p deletion including three candidate genes of EH: the ATP-dependent potassium channel Kir6.1, its regulator Sur2, and the phosphodiesterase PDE3A. They studied six affected and four nonaffected members of this family, using buttocks biopsies, mRNA extraction, and testing of small vessels using a myograph. Their data does not seem to support Kir6.1 and Sur2 as candidate genes for this syndrome. However, it does not disprove the hypothesis that Sur2 is a candidate gene of EH, because EH (which is a multifactorial disorder) appears to be different from this rare hereditary syndrome.
The present study is the first to examine correlation between the human Sur2 gene and EH using SNPs. We found that a haplotype of the Sur2 gene is a useful genetic marker of EH, and that Sur2 or a neighbouring gene is a susceptibility gene of EH.
